The World Trade Group Scientific Advisory Board is a group of recognised experts and practitionners from the life science industry.

The board meets a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.

The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.

Current Advisory Board Members Include:

	Dr. Thurloch O'Criodain Head of Quality, Pharma Ops Novartis Pharma AG
Thurloch O’Criodain is currently Head of Quality, Pharma Ops at Novartis Pharma. He has been working in Quality Management since 1980, spanning the medical device, pharmaceutical, and biotechnology industries. His expertise is especially strong in the areas of Quality Training, Quality Auditing, and Quality Improvement programmes, but is good right across all areas of quality management. He is recognised by the IMB as a Qualified Person in accordance with EU regulations.
	Jacques Dysli Head, Biotech Supply Chain Merck Serono
Andrew Thomson currently coordinates the Formulation Special Interest Group for BioProcess UK. Andrew has 10 years of experience in the pharmaceutical industry with AstraZeneca, PowderJect and Seattle Genetics. He has also worked with a huge variety of drug candidates at all stages of clinical development. This has included: antibody-drug conjugates, transdermal delivery powders, carbohydrates and cytotoxic materials. Andrew has a degree in Cell Biology from the University of Glasgow and a PhD in Biochemistry from the University of Kent.
	Marc-Antoine Perrissin-Fabert Head Technology and Product Support, Pharmaceutical Technology Center Solvay
Marc-Antoine is currently Knowledge & Innovation Manager at Solvay Pharmaceuticals in the Product Development & Support area. Being a pharmacist and having a PhD in general economics, Marc-Antoine started his industrial career in the production area, where he progressed through line functions and management experience. After 14 in this area and after significant experience in Technology Transfer, he understood that economics in production could be improved through better management of cost drivers and by embedding quality-in, during product development. He took responsibility in 2006 of a Global Technology Center supporting the Marketed products. Since June 2009, his current function allows him to both continue working on the Manufacturing interface with plants (where added value is being generated) and giving him opportunity to influence development to make better “Quality by Design”.
	Dr. Prabir Basu Executive Director NIPTE
Prabir Basu is the Executive Director of the National Institute for Pharmaceutical Technology and Education (NIPTE), a non-profit organization dedicated to basic research in pharmaceutical development and manufacturing science, and supported by eleven leading universities in the U.S. Dr. Basu is simultaneously the Managing Director of Pharmaceutical Technology and Education Center (PTEC), an interdisciplinary research institute at Purdue University. Prior to joining Purdue University in February, 2004, Dr. Basu worked in the pharmaceutical industry (Searle, Pharmacia and Pfizer) for over 20 years in various capacities in research, development, manufacturing, and outsourcing. Prabir Basu earned a Ph.D. in Chemical Engineering from the University of California, Berkeley and an MBA from Webster University in St. Louis, MO. Before joining Searle in 1984, Dr. Basu briefly taught Chemical Engineering at the Indian Institute of Technology, Kanpur in 1972 and worked for Hindustan Lever Limited, India from 1973 to 1983. He is a Fellow of the American Institute of Chemical Engineers and editor of the Journal of Validation Technology and Journal of GxP Compliance.
	Jonathan Walker Head, cLEAN® Program and Master Black Belt Novo Nordisk Pharmaceuticals
Jonathan served in several operational management roles after joining Novo Nordisk seven years ago in the United States. In January 2008 he was expatriated to corporate headquarters in Denmark to develop and lead the company cLEAN® Black Belt and Executive Sponsor Development programs. Jonathan supports strategic business alignment and process management systems as well as the corporate QbD deployment. He develops project leaders in the US, Europe, Brazil, and Asia, working in business areas including API, Biopharmaceutical, Finished, and Device Production, as well as in R&D, Quality and Logistics. Jonathan graduated from the University of Notre Dame and has an MBA from the University of North Carolina at Chapel Hill. Prior to joining Novo Nordisk, he served as a Captain in the US Army.
	Andrew Teasdale Senior QA Executive & Chair, Genotoxic Impurities Advisory Group AstraZeneca
Andrew Teasdale is currently a senior QA executive within AstraZeneca. His primary role is that of chair of the internal genotoxic impurities advisory group. This group is responsible for all matters relating to genotoxic impurities within the business, being responsible for both strategic direction and problem resolution. Andrew has been in QA since 2005 before which he was an analytical chemist in AstraZeneca. As well as his internal responsibilities Andrew leads 2 external groups working in the field of genotoxic impurities. One is an analytical group in the UK; the second, a Product Quality Research Institute (PQRI) working group , focusing on detailed studies of Sulphonate ester formation / decomposition.
	Olivia Darmuzey QbD Expert, Pharmaceutical Operations Novartis Pharma Stein AG
	Dr. Fadel Hamed Head of Operational Excellence, Genentech Product Operations
Dr. Fadel Hamed is an effective problem solver with an extensive background in process improvement, lean, and six sigma. He has more than 12 years of experience in multiple industries, including semiconductor, fiberoptics, and now, biotechnology. Prior to joining Genentech, Fadel worked at Amgen, IBM, and Lambda Optics. Fadel’s background combines skills in operations, manufacturing, quality, technical management, and strong leadership. He holds a doctorate in mechanical engineering from UC Berkeley and he is an ASQ certified six sigma black belt and quality engineer.
	Johan Van Den Bosch Senior Director External Manufacturing, Johnson & Johnson
Johan Van Den Bosch is currently Senior Director of External Manufacturing for Johnson & Johnson in Belgium. He is responsible for the management of European contract manufacturing partners, including all aspects of manufacturing and supply agreements. Johan trained as an industrial pharmacist and since then, has gained extensive experience in pharmaceutical manufacturing.

Application for membership

We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact: Gemma Fuller, Producer, Life Science Division, World Trade Group , T: +44 (0) 20 7202 7554

Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.